Treatment of chemotherapy-induced emesis
β
P. J. Hesketh
π
Article
π
1994
π
Springer-Verlag
π
English
β 730 KB
Paul J. Hesketh the optimal use of the 5-HT3 antagonists and their integration into clinical practice remain unanswered and are the appropriate focus for additional study.